Investigation of the in vivo interaction between ß-lactamase and its inhibitor protein

The affinity of ß-lactamase inhibitory protein (BLIP) for TEM-1 ß-lactamase has raised hopes in the challenge of protein-based inhibitor discovery for ß-lactamase-mediated antibiotic resistance. Currently, the effect of the formation of the ß-lactamase:BLIP complex in vivo in ß-lactam resistant bacteria is an open question. The scarcity of information to the extent to which BLIP can impair ß-lactamase activity inside cells has urged us to assess the in vivo efficacy of BLIP as a potent ß-lactamase inhibitor. To this end, ß-lactamase and BLIP were coexpressed in Escherichia coli. Simultaneous expression of ß-lactamase and BLIP and the formation of the TEM-1 ß-lactamase:BLIP complex in the periplasmic space of E. coli were verified by electrophoretic and Western blot techniques. Growth profiles of the cells expressing both ß-lactamase and its protein inhibitor, complemented with ß-lactamase activity measurements, suggested that BLIP synthesis retarded cell growth and reduced ß-lactamase activity. Although co-expression of ß-lactamase and its protein inhibitor did not completely impair cell growth, the specificity of BLIP enabled it to bind ß-lactamase in the bacterial periplasm, regardless of the crowding components.

Investigation of the in vivo interaction between ß-lactamase and its inhibitor protein

The affinity of ß-lactamase inhibitory protein (BLIP) for TEM-1 ß-lactamase has raised hopes in the challenge of protein-based inhibitor discovery for ß-lactamase-mediated antibiotic resistance. Currently, the effect of the formation of the ß-lactamase:BLIP complex in vivo in ß-lactam resistant bacteria is an open question. The scarcity of information to the extent to which BLIP can impair ß-lactamase activity inside cells has urged us to assess the in vivo efficacy of BLIP as a potent ß-lactamase inhibitor. To this end, ß-lactamase and BLIP were coexpressed in Escherichia coli. Simultaneous expression of ß-lactamase and BLIP and the formation of the TEM-1 ß-lactamase:BLIP complex in the periplasmic space of E. coli were verified by electrophoretic and Western blot techniques. Growth profiles of the cells expressing both ß-lactamase and its protein inhibitor, complemented with ß-lactamase activity measurements, suggested that BLIP synthesis retarded cell growth and reduced ß-lactamase activity. Although co-expression of ß-lactamase and its protein inhibitor did not completely impair cell growth, the specificity of BLIP enabled it to bind ß-lactamase in the bacterial periplasm, regardless of the crowding components.

___

  • Adelowo OO, Fagade OE (2012). Phylogenetic characterization, antimicrobial susceptibilities, and mechanisms of resistance in bacteria isolates from a poultry waste-polluted river, southwestern Nigeria. Turk J Biol 36: 37–45.
  • Alaybeyoglu B, Sariyar Akbulut B, Ozkirimli E (2015). A novel chimeric peptide with antimicrobial activity. J Pept Sci, accepted for publication.
  • Bebrone C, Moali C, Mahy F, Rival S, Docquier JD, Rossolini GM, Fastrez J, Pratt RF, Frere JM, Galleni M (2001). CENTA as a chromogenic substrate for studying beta-lactamases. Antimicrob Agents Ch 45: 1868–1871.
  • Blakesley RW, Boezi JA (1977). A new staining technique for proteins in polyacrylamide gels using Coomassie Brilliant Blue G250. Anal Biochem 82: 580–582.
  • Blazquez J, Baquero MR, Canton R, Alos I, Baquero F (1993). Characterization of a new TEM-type β-lactamase resistant to clavulanate, sulbactam, and tazobactam in a clinical isolate of Escherichia coli. Antimicrob Agents Ch 37: 2059–2063.
  • Bradford MM (1976). A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 72: 248–254.
  • Chanda S, Rakholiya K, Dholakia K, Baravalia Y (2013). Antimicrobial, antioxidant, and synergistic properties of two nutraceutical plants: Terminalia catappa L. and Colocasia esculenta L. Turk J Biol 37: 81–91.
  • Doran JL, Leskiw BK, Aippersbach S, Jensen SE (1990). Isolation and characterization of a beta-lactamase-inhibitory protein from Streptomyces clavuligerus and clonning and analysis of the corresponding gene. J Bacteriol 172: 4909–4918.
  • Essack SY (2001). The development of beta-lactam antibiotics in response to the evolution of beta-lactamases. Pharm Res 18: 1391–1399.
  • Frère JM (1995). Beta-lactamases and bacterial resistance to antibiotics. Mol Microbiol 16: 385–395.
  • Fryszczyn BG, Brown NG, Huang W, Balderas MA, Palzkill T (2011). Use of periplasmic target protein capture for phage display engineering of tight-binding protein-protein interactions. Protein Eng Des Sel 24: 819–828.
  • Hanes MS, Ratcliff K, Marqusee S, Handel TM (2010). Protein- protein binding affinities by pulse proteolysis: application to TEM-1/BLIP protein complexes. Protein Sci 19: 1996–2000.
  • Huang W, Petrosino J, Hirsch M, Shenkin PS, Palzkill T (1996). Amino acid sequence determinants of β-lactamase structure and activity. J Mol Biol 258: 688–703.
  • Huang W, Beharry Z, Zhang Z, Palzkill T (2003). A broad-spectrum peptide inhibitor of beta-lactamase identified using phage display and peptide arrays. Protein Eng 16: 853–860.
  • Jones RN, Wilson HW, Novick WJ, Barry AL, Thornsberry C (1982). In vitro evaluation of CENTA, a new beta-lactamase- susceptible chromogenic cephalosporin reagent. J Clin Microbiol 15: 954–958.
  • Khait R, Schreiber G (2012). FRETex: a FRET-based, high- throughput technique to analyze protein-protein interactions. Protein Eng Des Sel 25: 681–687.
  • Laemmli UK (1970). Cleavage of structural proteins during the assembly of the head of bacteriophage T4. Nature 227: 680– 685.
  • Majiduddin FK, Materon IC, Palzkill TG (2002). Molecular analysis of β-lactamase structure and function. Int J Med Microbiol 292: 127–137.
  • Martinez JL, Cercenado E, Rodriguez-Creixems M, Vicente-Perez, Delgado-Iribarren A, Baquero F (1987). Resistance to beta- lactam/clavulanate. Lancet 2: 1473.
  • Matagne A, Lamotte-Brasseur J, Frere JM (1998). Catalytic properties of class A β-lactamases: efficiency and diversity. Biochem J 330: 581–598.
  • Nossal NG, Heppel LA (1966). The release of enzymes by osmotic shock from Escherichia coli in exponential phase. J Biol Chem 241: 3055–3062.
  • Ozbalci C, Unsal C, Kazan D, Sariyar Akbulut B (2010). Proteomic response of Escherichia coli to the alkaloid extract of Papaver polychaetum. Ann Microbiol 60: 709–717.
  • Phichith D, Bun S, Padiolleau-Lefevre S, Guellier A, Banh S, Galleni M, Frere JM, Thomas D, Friboulet A, Avalle B (2010). Novel peptide inhibiting both TEM-1 b-lactamase and penicillin- binding proteins. FEBS J 277: 4965–4972.
  • Phillip Y, Kiss V, Schreiber G (2012a). Protein-binding dynamics imaged in a living cell. Proc Natl Acad Sci 109: 1461–1466.
  • Phillip Y, Harel M, Khait R, Qin S, Zhou HX, Schreiber G (2012b). Contrasting factors on the kinetic path to protein complex formation diminish the effects of crowding agents. Biophys J 103: 1011–1019.
  • Robert CH, Janin J (1998). A soft, mean-field potential derived from crystal contacts for predicting protein-protein interactions. J Mol Biol 283: 1037–1047.
  • Rudgers GW, Huang W, Palzkill T (2001). Binding properties of a peptide derived from beta-lactamase inhibitory protein. Antimicrob Agents Ch 45: 3279–3286.
  • Shevchenko A, Thomas H, Havlis J, Olsen JV, Mann M (2007). In-gel digestion for mass spectrometric characterization of proteins and proteomes. Nat Protoc 1: 2856–2860.
  • Strynadka NC, Jensen SE, Johns K, Blanchard H, Page M, Matagne A, Frere JM, James MN (1994). Structural and kinetic characterization of a beta-lactamase-inhibitor protein. Nature 368: 657–660.
  • Yuan J, Huang W, Chow DC, Palzkill T (2009). Fine mapping of the sequence requirements for binding of beta lactamase inhibitory protein (BLIP) to TEM-1 beta-lactamase using a genetic screen for BLIP function. J Mol Biol 389: 401–412.
Turkish Journal of Biology-Cover
  • ISSN: 1300-0152
  • Yayın Aralığı: Yılda 6 Sayı
  • Yayıncı: TÜBİTAK
Sayıdaki Diğer Makaleler

Aspects of mycorrhizal colonization in adaptation of sweet marjoram (Origanum majorana L.) grown on industrially polluted soil

Marieta HRISTOZKOVA, Maria GENEVA, İra STANCHEVA, Madlen BOYCHINOVA, Efrosina DJONOVA

Ultrastructural effects of lead acetate on the spleen of rats

MESURE TÜRKAY, HÜSEYİN TÜRKER, TURAN GÜVEN

Influence of carbon sources on growth and GC-MS based metabolite profiling of Arnica montana L. hairy roots

Maria PETROVA, Ely ZAYOVA, İvayla DINCHEVA, İlian BADJAKOV, Mariana VLAHOVA

Development of therapeutic proteins: advances and challenges

MUHAMMAD SAJID HAMID AKASH, KANWAL REHMAN, MUHAMMAD TARIQ, SHUQING CHEN

In vitro high frequency regeneration through apical shoot proliferation of Hemianthus callitrichoides `Cuba' - a multipurpose ornamental aquatic plant

Surendra BARPETE, Sancar Fatih ÖZCAN, Muhammad AASIM, Sebahattin ÖZCAN

Ploidy stability of Oryza sativa. L cv IR64 transformed with the moth bean P5CS gene with significant tolerance against drought and salinity

Arumugam Mohana PRIYA, Subramanian Radhesh KRISHNAN, Manikandan RAMESH

Whole-genome DNA methylation analysis in cotton ( Gossypium hirsutum L.) under diferent salt stresses

Xuke LU, Xiaojie ZHAO, Delong WANG, Zujun YIN, Junjuan WANG, Weili FAN, Shuai WANG, Tianbao ZHANG, Wuwei YE

Organ-specific antioxidant defenses and FT-IR spectroscopy of muscles in Crucian carp (Carassius auratus gibelio) exposed to environmental Pb2+

Sher Ali KHAN, Xiaoyu LIU, Hong LI, Wenting FAN, Bakht Ramin SHAH, Jingna LI, Lu ZHANG, Suyan CHEN, Sher Bahadar KHAN

Changes in gene expression in SIRT3 knockout liver cells

Randa TAO, Jamie LECLERC, Kübra YILDIZ, Seong-hoon PARK, Barbara JUNG, David GIUS, Özkan ÖZDEN

Histone deacetylase inhibitory activity of hydroxycapsaicin, a synthetic derivative of capsaicin, and its cytotoxic effects against human colon cancer cell lines

Thanaset SENAWONG, Paweena WONGPHAKHAM, Thussanee SAIWICHAI, Chanokbhorn PHAOSIRI, Pakit KUMBOONMA